New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

PHOENIX -- Hemodynamic and symptomatic benefits of mechanical thrombectomy for acute intermediate- to high-risk pulmonary embolism (PE) persisted to 6 months, the FLASH registry showed. Right ...

The use of mechanical thrombectomy (MT) was associated with reduced major adverse events in the short term and improved quality of life in the long term for pulmonary embolism (PE) patients with ...

PE or PEERLESS, the choice of therapy was shifting, influenced by patient factors and institutional protocols.

Please provide your email address to receive an email when new articles are posted on . Among patients with pulmonary embolism who underwent percutaneous thrombectomy, women experienced more procedure ...

WASHINGTON, DC — Large-bore mechanical thrombectomy is superior to catheter-directed thrombolysis for pulmonary embolism, according to a randomized trial comparing the two interventions. Although ...

HENDERSONVILLE, Tenn. (WSMV) - TriStar Hendersonville Medical Center announced the hospital’s first successful pulmonary thrombectomy. A pulmonary thrombectomy is a procedure that removes blood clots ...

June Hoffman's shortness of breath snuck up on her. It started in the morning, hardly noticeable as she got dressed for a routine visit to her rheumatologists office. But by the time she reached the ...

NEW ORLEANS -- Large-bore mechanical thrombectomy for high-risk pulmonary embolism (PE) was associated with fewer major adverse outcomes than other approaches, the FLAME study showed. Clot removal ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced positive efficacy and safety results from the pivotal SYMPHONY-PE Trial (NCT06062329) evaluating the company’s Symphony® ...

Six month outcomes from the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) registry were presented today as late-breaking clinical research at the Society for ...